135 related articles for article (PubMed ID: 12702578)
1. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients.
Taback B; Giuliano AE; Lai R; Hansen N; Singer FR; Pantel K; Hoon DS
Ann N Y Acad Sci; 2006 Sep; 1075():211-21. PubMed ID: 17108214
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
Taback B; Fujiwara Y; Wang HJ; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 2001 Aug; 61(15):5723-6. PubMed ID: 11479206
[TBL] [Abstract][Full Text] [Related]
6. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P
Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596
[TBL] [Abstract][Full Text] [Related]
7. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.
Schwarzenbach H; Müller V; Beeger C; Gottberg M; Stahmann N; Pantel K
Breast Cancer Res; 2007; 9(5):R66. PubMed ID: 17915011
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.
Schwarzenbach H; Eichelser C; Kropidlowski J; Janni W; Rack B; Pantel K
Clin Cancer Res; 2012 Oct; 18(20):5719-30. PubMed ID: 23014523
[TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
Zhang H; Li Z; Chen M; Zhang G; Xu K
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
[TBL] [Abstract][Full Text] [Related]
12. Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer.
Wascher RA; Huynh KT; Giuliano AE; Hansen NM; Singer FR; Elashoff D; Hoon DS
Clin Cancer Res; 2003 Apr; 9(4):1427-35. PubMed ID: 12684415
[TBL] [Abstract][Full Text] [Related]
13. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.
Schwarzenbach H; Pantel K; Kemper B; Beeger C; Otterbach F; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(5):R71. PubMed ID: 19772563
[TBL] [Abstract][Full Text] [Related]
16. Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
Fujiwara Y; Chi DD; Wang H; Keleman P; Morton DL; Turner R; Hoon DS
Cancer Res; 1999 Apr; 59(7):1567-71. PubMed ID: 10197630
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients.
Taback B; Saha S; Hoon DS
Ann N Y Acad Sci; 2006 Sep; 1075():197-203. PubMed ID: 17108212
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in ductal lavage for breast tumor and the contralateral breast.
Yonekura Y; Yamamoto D; Okugawa H; Tanaka K; Kamiyama Y
Oncol Rep; 2005 Apr; 13(4):739-43. PubMed ID: 15756451
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
20. Location of several putative genes possibly involved in human breast cancer progression.
Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R
Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
